News | November 13, 2023
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
he company posted total income during Q2 FY24 at Rs. 12.86 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Good momentum in commercial CDMO business
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Subscribe To Our Newsletter & Stay Updated
